The Impaired Airway: Guidelines on Management Mark S. Regan, M.D. Initiate therapy for asthma based on severity. Monitor and adjust asthma therapy based on control of symptoms and/or peak flow variation. Select appropriate agents for the treatment of chronic obstructive pulmonary disease. Use directed testing and empiric therapy to identify causes of chronic cough. Optimize therapy before ruling out possible contributors to chronic cough. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Pediatric Respiratory Emergencies Andrea Marmor, M.D. Elaborate on the similarities and differences between croup, epiglottitis, tracheitis, and retropharyngeal abscess. Diagnose and treat anaphylaxis and airway burns. Diagnose foreign body aspiration using history, physical examination, x-rays, and/or rigid bronchoscopy. Manage the child with an acute exacerbation of asthma or status asthmaticus. Review the absolute and relative indications for intubation in the child with lower airway obstruction. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Respiratory Health in Women Anne Dixon, M.D. and Gary Elkins, Ph.D. Summarize the pathophysiology of asthma in women. Choose among treatment alternatives for women with asthma. Recommend appropriate treatments for pregnant women with asthma. Create a smoking cessation treatment plan for women using hypnotherapy. Assess factors influencing success of smoking cessation for an individual. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Topics in Respiratory Illnesses Michael, M.D., M.S. and Susan J. Little, M.D. Confirm the diagnosis in patients with suspected asthma. Initiate and/or adjust long-term asthma control therapy. Effectively treat asthma exacerbations and prescribe appropriate discharge therapy. Identify and inoculate individuals classified as high-priority for influenza A H1N1 vaccination. Effectively diagnose and treat patients with suspected influenza. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Asthma: Medications and Mechanisms Harold S. Nelson, M.D. and Phil Lieberman, M.D. Describe concerns about the safety of long-acting beta-agonists (LABAs). Discuss the studies that examined the particular risk with LABAs in blacks, people with arginine 16 beta2-adrenergic receptor genotypes, and children and adolescents. Consider the effect on safety of adding an inhaled corticosteroid (ICS) to a LABA. Describe the mechanisms underlying the remodeling process in asthma. Evaluate the potential of therapy to prevent remodeling. CME Qualifies for a maximum 2 AMA PRA Category 1 Credits ™
Additional Continuing Education Options Available...
If you have taken the current Comprehensive Respiratory Medicine seminar listed above or if you are seeking additional continuing Medical education credits, please visit: New Medical Courses & Medical Courses Coming Soon to see abbreviated listings of additional courses available or courses that will be available soon.
You may also be interested in one of our NEW Specialties. Click the links below for the current course outline and full information!
Here's what our clients are saying about American Seminar Institute's CME seminars...
"...lectures were relevant and well presented. I chose to take the Comprehensive Respiratory Medicine seminar in New York City and was thrilled to have the convenience of a flexible schedule!" Terry, MD,Sarasota, FL
" I took (ASI's Comprehensive Respiratory Medicine Review course)in the Dominican Republic and was impressed with the content and ease of the whole program..thank you, I'll be back next year.." Jordan, MD, San Diego, CA
" ..this was the perfect, flexible, learning situation for me...I enjoyed the Comprehensive Respiratory Medicine seminar while also enjoying South Beach, Miami..." Greg, MD, Dayton, OH
Back to Top of Comprehensive Respiratory Medicine CME Review Page
